Axonal degeneration is controlled by the TIR domain NADase SARM1. In this issue of Neuron, Figley et al. (2021) reveal a key regulatory mechanism that controls SARM1's enzymatic activity, providing insight into how NAD+ biosynthesis by the NMNAT2 enzyme protects axons, and a new therapeutic path to tune SARM1 activity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.neuron.2021.03.021 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!